- Capital Cube•8 days ago
Categories: Yahoo Finance Get free summary analysis Cannabis Science, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Cannabis Science, Inc. – Ignyta, Inc., Elite Pharmaceuticals, Inc., Radius Health Inc and Chimerix, Inc. (RXDX-US, ELTP-US, RDUS-US and CMRX-US) that have also reported for this period. Highlights ... Read more (Read more...)
- Marketwired•16 days agoHarvard Director of Global Health Catalyst at the World-Renowned Dana Farber/Harvard Cancer Center States: Cannabis Science Presentation and Discussions a Great Success for Mutually Beneficial Partnership Opportunities with Harvard Medical School
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, proudly announced that following its presentation to Harvard Medical School, the Harvard Director of ...
- Marketwired•21 days agoCannabis Science Announces Initiation of Studies into Intravenous Therapy (IV) Transfer of CBD/THC Rich Extracts for Pulmonary Patients
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that plans to initiate a long awaited medication study for Pulmonary Patients ...
CBIS : Summary for CANNABIS SCIENCE I COM USD0.001 - Yahoo Finance
Cannabis Science, Inc. (CBIS)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|